{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:36:47Z","timestamp":1787243807359,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21-NS107950"],"award-info":[{"award-number":["R21-NS107950"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54-NS110435"],"award-info":[{"award-number":["U54-NS110435"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS109209"],"award-info":[{"award-number":["R01-NS109209"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009578","name":"Mizutani Foundation for Glycoscience","doi-asserted-by":"publisher","award":["200045"],"award-info":[{"award-number":["200045"]}],"id":[{"id":"10.13039\/100009578","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["R01-NS109209"],"award-info":[{"award-number":["R01-NS109209"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["U54-NS110435"],"award-info":[{"award-number":["U54-NS110435"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020304","name":"Dinosaur Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bbalip.2023.159350","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T03:50:25Z","timestamp":1686887425000},"page":"159350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["GM1 oligosaccharide efficacy against \u03b1-synuclein aggregation and toxicity in vitro"],"prefix":"10.1016","volume":"1868","author":[{"given":"Maria","family":"Fazzari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Zaccagnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblle","family":"Callizot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Ciampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Veronica","family":"Carsana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Loberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Aureli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Civera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vasile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8180-5908","authenticated-orcid":false,"given":"Sandro","family":"Sonnino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7431-9207","authenticated-orcid":false,"given":"Elena","family":"Chiricozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Lunghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2023.159350_bb0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1432-1327.1998.2570293.x","article-title":"IUPAC-IUB joint commission on biochemical nomenclature (JCBN). Nomenclature of glycolipids\u2013recommendations 1997","volume":"257","author":"Chester","year":"1998","journal-title":"Eur J Biochem."},{"key":"10.1016\/j.bbalip.2023.159350_bb0010","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.bbalip.2023.159350_bb0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/bs.pmbts.2017.12.009","article-title":"Gangliosides, \u03b1-synuclein, and Parkinson\u2019s disease","volume":"156","author":"Ledeen","year":"2018","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.bbalip.2023.159350_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228645","article-title":"The role of \u03b1-synuclein oligomers in Parkinson\u2019s disease","volume":"21","author":"Du","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2023.159350_bb0025","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1523\/JNEUROSCI.19-14-05782.1999","article-title":"alpha-Synuclein shares physical and functional homology with 14-3-3 proteins","volume":"19","author":"Ostrerova","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2023.159350_bb0030","first-page":"239","article-title":"Alpha-Synuclein forms a complex with transcription factor Elk-1","volume":"77","author":"Iwata","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2023.159350_bb0035","doi-asserted-by":"crossref","first-page":"12334","DOI":"10.1074\/jbc.M110414200","article-title":"alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells","volume":"277","author":"Ahn","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159350_bb0040","doi-asserted-by":"crossref","first-page":"15345","DOI":"10.1074\/jbc.M111.318949","article-title":"\u03b1-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer","volume":"287","author":"Fauvet","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159350_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.bbalip.2023.159350_bb0050","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron."},{"key":"10.1016\/j.bbalip.2023.159350_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103727","article-title":"N-alpha-acetylation of \u03b1-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation","volume":"9","author":"Bartels","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2023.159350_bb0060","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/bi061749a","article-title":"GM1 specifically interacts with alpha-synuclein and inhibits fibrillation","volume":"46","author":"Martinez","year":"2007","journal-title":"Biochemistry."},{"key":"10.1016\/j.bbalip.2023.159350_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-8552-4_2","article-title":"Gangliosides of the nervous system","volume":"1804","author":"Ledeen","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbalip.2023.159350_bb0070","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s11064-011-0437-y","article-title":"Mice lacking major brain gangliosides develop parkinsonism","volume":"36","author":"Wu","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbalip.2023.159350_bb0075","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jnr.23090","article-title":"Deficiency of ganglioside GM1 correlates with Parkinson\u2019s disease in mice and humans","volume":"90","author":"Wu","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbalip.2023.159350_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10719-021-10025-9","article-title":"Systemic deficiency of GM1 ganglioside in Parkinson\u2019s disease tissues and its relation to the disease etiology","volume":"39","author":"Ledeen","year":"2022","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbalip.2023.159350_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11010209","article-title":"Age-related decline in gangliosides GM1 and GD1a in non-CNS tissues of normal mice: implications for peripheral symptoms of Parkinson\u2019s disease","volume":"11","author":"Chowdhury","year":"2023","journal-title":"Biomedicines."},{"key":"10.1016\/j.bbalip.2023.159350_bb0090","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41401-020-0454-y","article-title":"Autophagy-dependent removal of \u03b1-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson\u2019s disease","volume":"42","author":"Guo","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbalip.2023.159350_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-021-02374-x","article-title":"Anti-inflammatory role of GM1 and other gangliosides on microglia","volume":"19","author":"Galleguillos","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbalip.2023.159350_bb0100","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1038\/s41598-019-42847-x","article-title":"GM1 ganglioside modifies \u03b1-synuclein toxicity and is neuroprotective in a rat \u03b1-synuclein model of Parkinson\u2019s disease","volume":"9","author":"Schneider","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2023.159350_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10719-021-09974-y","article-title":"Turning the spotlight on the oligosaccharide chain of GM1 ganglioside","volume":"38","author":"Chiricozzi","year":"2021","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbalip.2023.159350_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082858","article-title":"GM1 oligosaccharide crosses the human blood-brain barrier in vitro by a paracellular route","volume":"21","author":"Di Biase","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2023.159350_bb0115","doi-asserted-by":"crossref","first-page":"19330","DOI":"10.1038\/s41598-019-55885-2","article-title":"Parkinson\u2019s disease recovery by GM1 oligosaccharide treatment in the B4galnt1+\/\u2212 mouse model","volume":"9","author":"Chiricozzi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2023.159350_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215277","article-title":"Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins","volume":"14","author":"Callizot","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2023.159350_bb0125","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1096\/fj.07-095398","article-title":"PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson\u2019s disease","volume":"22","author":"Visanji","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2023.159350_bb0130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2023.159350_bb0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10719-020-09919-x","article-title":"Gangliosides in the differentiation process of primary neurons: the specific role of GM1-oligosaccharide","volume":"37","author":"Di Biase","year":"2020","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbalip.2023.159350_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179864","article-title":"Alpha-synuclein: the spark that flames dopaminergic neurons, in vitro and in vivo evidence","volume":"23","author":"Henriques","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2023.159350_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-1-4939-9124-2_20","article-title":"Expression and purification of untagged \u03b1-synuclein","volume":"1948","author":"Powers","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbalip.2023.159350_bb0150","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10719-020-09963-7","article-title":"Modulation of calcium signaling depends on the oligosaccharide of GM1 in Neuro2a mouse neuroblastoma cells","volume":"37","author":"Lunghi","year":"2020","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbalip.2023.159350_bb0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10719-020-09920-4","article-title":"The oligosaccharide portion of ganglioside GM1 regulates mitochondrial function in neuroblastoma cells","volume":"37","author":"Fazzari","year":"2020","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbalip.2023.159350_bb0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0005-2760(73)90055-6","article-title":"A new procedure for the extraction, purification and fractionation of brain gangliosides","volume":"296","author":"Tettamanti","year":"1973","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2023.159350_bb0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1432-1033.1994.00271.x","article-title":"Geometrical and conformational properties of ganglioside GalNAc-GD1a, IV4GalNAcIV3Neu5AcII3Neu5AcGgOse4Cer","volume":"225","author":"Acquotti","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbalip.2023.159350_bb0170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/mds.24051","article-title":"Toward a redefinition of Parkinson\u2019s disease","volume":"27","author":"Stern","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbalip.2023.159350_bb0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000320027","article-title":"MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain","volume":"18","author":"Lofrumento","year":"2011","journal-title":"Neuroimmunomodulation."},{"key":"10.1016\/j.bbalip.2023.159350_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2022.103729","article-title":"GM1 ganglioside modifies microglial and neuroinflammatory responses to \u03b1-synuclein in the rat AAV-A53T \u03b1-synuclein model of Parkinson\u2019s disease","volume":"120","author":"Schneider","year":"2022","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbalip.2023.159350_bb0185","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/anie.200390233","article-title":"NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors","volume":"42","author":"Meyer","year":"2003","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bbalip.2023.159350_bb0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/glycob\/cwx092","article-title":"NMR interaction studies of Neu5Ac-\u03b1-(2,6)-Gal-\u03b2-(1-4)-GlcNAc with influenza-virus hemagglutinin expressed in transfected human cells","volume":"28","author":"Vasile","year":"2018","journal-title":"Glycobiology."},{"key":"10.1016\/j.bbalip.2023.159350_bb0195","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1002\/ejoc.201403014","article-title":"Diffusion-ordered spectroscopy and saturation transfer difference NMR spectroscopy studies of selective interactions between ELAV protein fragments and an mRNA target","volume":"2014","author":"Vasile","year":"2014","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bbalip.2023.159350_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113284","article-title":"Mice deficient in GM1 manifest both motor and non-motor symptoms of Parkinson\u2019s disease; successful treatment with synthetic GM1 ganglioside","volume":"329","author":"Wu","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbalip.2023.159350_bb0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0005-2760(89)90175-6","article-title":"Human brain gangliosides: developmental changes from early fetal stage to advanced age","volume":"1005","author":"Svennerholm","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2023.159350_bb0210","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1046\/j.1471-4159.1994.63051802.x","article-title":"Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years","volume":"63","author":"Svennerholm","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2023.159350_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020363","article-title":"Gangliosides and the treatment of neurodegenerative diseases: a long Italian tradition","volume":"10","author":"Fazzari","year":"2022","journal-title":"Biomedicines."},{"key":"10.1016\/j.bbalip.2023.159350_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030868","article-title":"GM1 ganglioside is a key factor in maintaining the mammalian neuronal functions avoiding neurodegeneration","volume":"21","author":"Chiricozzi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2023.159350_bb0225","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3389\/fneur.2019.00859","article-title":"Gangliosides: treatment avenues in neurodegenerative disease","volume":"10","author":"Magistretti","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbalip.2023.159350_bb0230","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/jnc.14146","article-title":"Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells","volume":"143","author":"Chiricozzi","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2023.159350_bb0235","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10719-020-09919-x","article-title":"Gangliosides in the differentiation process of primary neurons: the specific role of GM1-oligosaccharide","volume":"37","author":"Di Biase","year":"2020","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbalip.2023.159350_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082858","article-title":"GM1 oligosaccharide crosses the human blood-brain barrier in vitro by a paracellular route","volume":"21","author":"Di Biase","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2023.159350_bb0245","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.abb8587","article-title":"Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases","volume":"370","author":"Bartels","year":"2020","journal-title":"Science."},{"key":"10.1016\/j.bbalip.2023.159350_bb0250","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/glia.23312","article-title":"NGF steers microglia toward a neuroprotective phenotype","volume":"66","author":"Rizzi","year":"2018","journal-title":"Glia."},{"key":"10.1016\/j.bbalip.2023.159350_bb0255","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1007\/s12035-019-1556-8","article-title":"The neuroprotective role of the GM1 oligosaccharide, II(3)Neu5Ac-Gg4, in neuroblastoma cells","volume":"56","author":"Chiricozzi","year":"2019","journal-title":"Mol Neurobiol."},{"key":"10.1016\/j.bbalip.2023.159350_bb0260","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2023.159350_bb0265","doi-asserted-by":"crossref","first-page":"1103416","DOI":"10.3389\/fneur.2023.1103416","article-title":"Microglia activation in central nervous system disorders: a review of recent mechanistic investigations and development efforts","volume":"14","author":"Qin","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbalip.2023.159350_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071083","article-title":"Alpha-synuclein preformed fibrils bind to beta-neurexins and impair beta-neurexin-mediated presynaptic organization","volume":"12","author":"Feller","year":"2023","journal-title":"Cells."},{"key":"10.1016\/j.bbalip.2023.159350_bb0275","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of alpha-synuclein in its free and lipid-associated states","volume":"307","author":"Eliezer","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbalip.2023.159350_bb0280","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nbd.2014.05.031","article-title":"Lysine residues at the first and second KTKEGV repeats mediate alpha-Synuclein binding to membrane phospholipids","volume":"70","author":"Zarbiv","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2023.159350_bb0285","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1021\/ja208316h","article-title":"alpha-Synuclein induces both positive mean curvature and negative Gaussian curvature in membranes","volume":"134","author":"Braun","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbalip.2023.159350_bb0290","doi-asserted-by":"crossref","first-page":"40186","DOI":"10.1074\/jbc.M305326200","article-title":"The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation","volume":"278","author":"Zhu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159350_bb0295","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"Alpha-synuclein, especially the Parkinson\u2019s disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbalip.2023.159350_bb0300","doi-asserted-by":"crossref","first-page":"14369","DOI":"10.1021\/bi701275p","article-title":"Helical alpha-synuclein forms highly conductive ion channels","volume":"46","author":"Zakharov","year":"2007","journal-title":"Biochemistry."},{"key":"10.1016\/j.bbalip.2023.159350_bb0305","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1073\/pnas.0502066102","article-title":"Amyloid ion channels: a common structural link for protein-misfolding disease","volume":"102","author":"Quist","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2023.159350_bb0310","series-title":"Glycoconjugate Journal","article-title":"Modulation of calcium signaling depends on the oligosaccharide of GM1 in Neuro2a mouse neuroblastoma cells","author":"Lunghi","year":"2020"},{"key":"10.1016\/j.bbalip.2023.159350_bb0315","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41401-020-0454-y","article-title":"Autophagy-dependent removal of alpha-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson\u2019s disease","volume":"42","author":"Guo","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbalip.2023.159350_bb0320","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1007\/s12035-019-1556-8","article-title":"The neuroprotective role of the GM1 oligosaccharide, II3Neu5Ac-Gg4, in neuroblastoma cells","volume":"56","author":"Chiricozzi","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbalip.2023.159350_bb0325","doi-asserted-by":"crossref","first-page":"23622","DOI":"10.1074\/jbc.M313784200","article-title":"Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson\u2019s disease","volume":"279","author":"Hashimoto","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159350_bb0330","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1471-4159.1988.tb04867.x","article-title":"Oligosaccharide portion of GM1 enhances process formation by S20Y neuroblastoma cells","volume":"51","author":"Schengrund","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2023.159350_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143351","article-title":"Intraventricular sialidase administration enhances GM1 ganglioside expression and is partially neuroprotective in a mouse model of Parkinson\u2019s disease","volume":"10","author":"Schneider","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2023.159350_bb0340","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.expneurol.2014.10.010","article-title":"GDNF signaling implemented by GM1 ganglioside; failure in Parkinson\u2019s disease and GM1-deficient murine model","volume":"263","author":"Hadaczek","year":"2015","journal-title":"Exp. Neurol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198123000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198123000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:21:58Z","timestamp":1778811718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198123000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1388198123000744"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2023.159350","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GM1 oligosaccharide efficacy against \u03b1-synuclein aggregation and toxicity in vitro","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2023.159350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"159350"}}